A1GI34 Stock Overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Agilent Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$346.07 |
| 52 Week High | US$360.35 |
| 52 Week Low | US$275.24 |
| Beta | 1.12 |
| 1 Month Change | 5.38% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -1.82% |
| 5 Year Change | n/a |
| Change since IPO | 89.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| A1GI34 | BR Life Sciences | BR Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how A1GI34 performed against the BR Life Sciences industry.
Return vs Market: Insufficient data to determine how A1GI34 performed against the BR Market.
Price Volatility
| A1GI34 volatility | |
|---|---|
| A1GI34 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in BR Market | 0% |
| 10% least volatile stocks in BR Market | 0% |
Stable Share Price: A1GI34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine A1GI34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 17,700 | Padraig McDonnell | www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Agilent Technologies, Inc. Fundamentals Summary
| A1GI34 fundamental statistics | |
|---|---|
| Market cap | R$210.09b |
| Earnings (TTM) | R$6.27b |
| Revenue (TTM) | R$34.18b |
33.5x
P/E Ratio6.1x
P/S RatioIs A1GI34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A1GI34 income statement (TTM) | |
|---|---|
| Revenue | US$6.74b |
| Cost of Revenue | US$3.33b |
| Gross Profit | US$3.41b |
| Other Expenses | US$2.17b |
| Earnings | US$1.24b |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
May 29, 2024
| Earnings per share (EPS) | 4.22 |
| Gross Margin | 50.56% |
| Net Profit Margin | 18.35% |
| Debt/Equity Ratio | 41.3% |
How did A1GI34 perform over the long term?
See historical performance and comparison